Abstract
The US Vaccine Adverse Event Reporting System contains case reports of autoimmune diseases (ADs) occurring following vaccinations. ADs are rare and occur in unvaccinated people, making the potential association between vaccines and ADs challenging to evaluate. Developing mechanistic pathways that link genes, immune mediators, vaccine components and ADs would be helpful for hypothesis generation, enhancing theories of biologic plausibility and grouping rare autoimmune adverse events to increase the ability to detect and evaluate safety signals. Here, we propose a conceptual framework for investigating the genetics of ADs as safety signals following vaccination, potentially contributing to the identification of relevant biomarkers. We also discuss a study design that incorporates genetic information into postmarket clinical evaluation of autoimmune adverse events following vaccination.
Original language | English (US) |
---|---|
Pages (from-to) | 1107-1120 |
Number of pages | 14 |
Journal | Biomarkers in Medicine |
Volume | 9 |
Issue number | 11 |
DOIs | |
State | Published - Nov 2015 |
Keywords
- biologic plausibility
- genetics of autoimmune diseases
- molecular biomarkers
- rare adverse events
- vaccine safety
- vaccinomics
ASJC Scopus subject areas
- Drug Discovery
- Clinical Biochemistry
- Biochemistry, medical